Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 03, 2020 09:20 ET | Source: Liquidia Technologies, Inc.

Liquidia to Report Second Quarter 2020 Financial Results and Provide Corporate Update on August 10, 2020

RESEARCH TRIANGLE PARK, N.C., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq:LQDA), a late-stage clinical biopharmaceutical company focused on the development and...
July 24, 2020 09:08 ET | Source: Liquidia Technologies, Inc.

Liquidia Responds to United Therapeutics Corporation Lawsuit Alleging Infringement of New Tyvaso Patent

RESEARCH TRIANGLE PARK, N.C., July 24, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA), a late-stage clinical biopharmaceutical company focused on the development and...
July 02, 2020 16:01 ET | Source: Liquidia Technologies, Inc.

Liquidia Announces Closing of Public Offering of Common Stock

RESEARCH TRIANGLE PARK, N.C., July 02, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development and...
June 29, 2020 22:45 ET | Source: Liquidia Technologies, Inc.

Liquidia to Host Conference Call to Provide Update on Recent Announcements

RESEARCH TRIANGLE PARK, N.C., June 29, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development and...
June 29, 2020 22:30 ET | Source: Liquidia Technologies, Inc.

Liquidia Announces Pricing of Public Offering of Common Stock

RESEARCH TRIANGLE PARK, N.C., June 29, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development and...
June 29, 2020 16:05 ET | Source: Liquidia Technologies, Inc.

Liquidia Announces Proposed Offering of Common Stock

RESEARCH TRIANGLE PARK, N.C., June 29, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development and...
June 29, 2020 16:01 ET | Source: Liquidia Technologies, Inc.

Liquidia to Acquire RareGen, LLC, and Expand Presence in PAH

Acquisition Bolsters Liquidia’s Capabilities in Pulmonary Arterial Hypertension (PAH) and Commercial Readiness for LIQ861, if ApprovedTwo New Directors, - Roger Jeffs, Ph.D. and Paul Manning, to Join...
June 05, 2020 15:30 ET | Source: Liquidia Technologies, Inc.

Liquidia Responds to United Therapeutics Corporation Lawsuit Alleging Infringement of Tyvaso Patents

RESEARCH TRIANGLE PARK, N.C., June 05, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA), a late-stage clinical biopharmaceutical company focused on the development and...
May 27, 2020 20:04 ET | Source: Liquidia Technologies, Inc.

Liquidia to Present at the Jefferies Virtual Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., May 27, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA), a late-stage clinical biopharmaceutical company focused on the development and...
May 18, 2020 07:15 ET | Source: Liquidia Technologies, Inc.

Liquidia Appoints Tushar Shah, M.D., as Chief Medical Officer

RESEARCH TRIANGLE PARK, N.C., May 18, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA), a late-stage clinical biopharmaceutical company focused on the development and...